AR110356A1 - PROCESS FOR THE PREPARATION OF 2- (3- (FLUORMET) AZETIDIN-1-IL) ETAN-1-OL - Google Patents
PROCESS FOR THE PREPARATION OF 2- (3- (FLUORMET) AZETIDIN-1-IL) ETAN-1-OLInfo
- Publication number
- AR110356A1 AR110356A1 ARP170103481A ARP170103481A AR110356A1 AR 110356 A1 AR110356 A1 AR 110356A1 AR P170103481 A ARP170103481 A AR P170103481A AR P170103481 A ARP170103481 A AR P170103481A AR 110356 A1 AR110356 A1 AR 110356A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- azetidin
- fluoromethyl
- tetrahydro
- oxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Se describen métodos de preparación de 2-(3-(fluormetil)azetidin-1-il)etan-1-ol de fórmula (1), un producto intermedio útil para la síntesis de compuestos modulares del receptor de estrógeno. Reivindicación 1: Un proceso para la preparación de 2-(3-(fluormetil)azetidin-1-il)etan-1-ol de fórmula (1) que comprende hacer reaccionar 3-(fluormetil)azetidina de fórmula (2), glioxalato de etilo, y un primer agente reductor de hidruro para formar 2-(3-(fluormetil)azetidin-1-il)acetato de etilo de fórmula (3); y hacer reaccionar el compuesto de fórmula (3) con un segundo agente reductor de hidruro para formar el compuesto de fórmula (1). Reivindicación 17: El proceso de la reivindicación 1, que además comprende hacer reaccionar el compuesto de fórmula (1) y 2-(4-yodofenil)-4-metil-6-((tetrahidro-2H-piran-2-il)oxi)-3-(3-((tetrahidro-2H-piran-2-il)oxi)-2H-cromeno de fórmula (4) para formar 3-(fluormetil)-1-(2-(4-(4-metil-6-((tetrahidro-2H-piran-2-il)oxi)-3-(3-((tetrahidro-2H-piran-2-il)oxi)fenil)-2H-cromen-2-il)fenoxi)etil)azetidina de fórmula (5). Reivindicación 18: El proceso de la reivindicación 17, que además comprende hacer reaccionar el compuesto de fórmula (5) con ácido acético acuoso para formar 2-(4-(2-(3-(fluormetil)azetidin-1-ii)etoxi)fenil)-3-(3-hidroxifenil)-4-metil-2H-cromen-6-ol de fórmula (6).Methods of preparing 2- (3- (fluoromethyl) azetidin-1-yl) ethan-1-ol of formula (1), an intermediate useful for the synthesis of estrogen receptor modular compounds, are described. Claim 1: A process for the preparation of 2- (3- (fluormethyl) azetidin-1-yl) ethan-1-ol of formula (1) comprising reacting 3- (fluormethyl) azetidine of formula (2), glyoxalate ethyl, and a first hydride reducing agent to form ethyl 2- (3- (fluoromethyl) azetidin-1-yl) acetate of formula (3); and reacting the compound of formula (3) with a second hydride reducing agent to form the compound of formula (1). Claim 17: The process of claim 1, further comprising reacting the compound of formula (1) and 2- (4-iodophenyl) -4-methyl-6 - ((tetrahydro-2H-pyran-2-yl) oxy ) -3- (3 - ((tetrahydro-2H-pyran-2-yl) oxy) -2H-chromene of formula (4) to form 3- (fluoromethyl) -1- (2- (4- (4-methyl -6 - ((tetrahydro-2H-piran-2-yl) oxy) -3- (3 - ((tetrahydro-2H-piran-2-yl) oxy) phenyl) -2H-chromen-2-yl) phenoxy) ethyl) azetidine of formula (5) Claim 18: The process of claim 17, further comprising reacting the compound of formula (5) with aqueous acetic acid to form 2- (4- (2- (3- (fluoromethyl) ) azetidin-1-ii) ethoxy) phenyl) -3- (3-hydroxyphenyl) -4-methyl-2H-chromen-6-ol of formula (6).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662432837P | 2016-12-12 | 2016-12-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR110356A1 true AR110356A1 (en) | 2019-03-20 |
Family
ID=60935792
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP170103481A AR110356A1 (en) | 2016-12-12 | 2017-12-13 | PROCESS FOR THE PREPARATION OF 2- (3- (FLUORMET) AZETIDIN-1-IL) ETAN-1-OL |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR110356A1 (en) |
WO (1) | WO2018108954A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI702219B (en) | 2018-07-12 | 2020-08-21 | 美商美國禮來大藥廠 | Selective estrogen receptor degraders |
CN114933551B (en) * | 2022-06-28 | 2023-06-30 | 吉尔多肽生物制药(大连市)有限公司 | Synthesis method of chiral Fmoc-3-amino-2- (tert-butoxymethyl) propionic acid |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008514595A (en) * | 2004-09-24 | 2008-05-08 | アストラゼネカ・アクチエボラーグ | Compound, composition containing it, its production and its use II |
NZ566793A (en) * | 2005-08-24 | 2010-03-26 | Eisai R&D Man Co Ltd | Novel pyridine derivative and pyrimidine derivative |
EA029559B1 (en) | 2011-12-14 | 2018-04-30 | Серагон Фармасьютикалс, Инк. | Fluorinated estrogen receptor modulators and use thereof |
AU2014281511A1 (en) | 2013-06-19 | 2015-12-03 | Seragon Pharmaceuticals, Inc. | Estrogen receptor modulator and uses thereof |
RU2015152171A (en) | 2013-06-19 | 2017-07-25 | Серагон Фармасьютикалз, Инк. | ASETIDINE MODULATORS OF ESTROGEN RECEPTORS AND THEIR APPLICATION |
KR102559719B1 (en) | 2014-12-18 | 2023-07-26 | 에프. 호프만-라 로슈 아게 | TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF |
WO2016097071A1 (en) | 2014-12-18 | 2016-06-23 | F. Hoffmann-La Roche Ag | Estrogen receptor modulators and uses thereof |
EP3233818A1 (en) | 2014-12-18 | 2017-10-25 | F. Hoffmann-La Roche AG | Derivatives of 2,3-diphenylchromene useful for the treatment of cancer |
-
2017
- 2017-12-12 WO PCT/EP2017/082493 patent/WO2018108954A1/en active Application Filing
- 2017-12-13 AR ARP170103481A patent/AR110356A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2018108954A1 (en) | 2018-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR110356A1 (en) | PROCESS FOR THE PREPARATION OF 2- (3- (FLUORMET) AZETIDIN-1-IL) ETAN-1-OL | |
PE20070425A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING 1- [4- (2-AZEPAN-1-IL-ETOXY) -BENZYL] -2- (4-HYDROXYPHENYL) -3-METHYL-1H-INDOL-5-OL ACETATE (BAZEDOXIFENO ACETATE) AS A SELECTIVE MODULATOR OF THE ESTROGEN RECEPTOR | |
AR094588A2 (en) | PROCESS FOR OBTAINING A COMPOSITE DERIVED FROM BENZIMIDAZOL AND PHARMACEUTICAL COMPOSITION | |
MY174629A (en) | Manufacture of 2-(5-bromo-4(4-cyclopropylnaphalen-1-yl)- 4h-1,2,4-triazol-3-ylthio)acetic acid | |
CL2011002840A1 (en) | Compound derived from pyrazole carboxamide; fungicidal composition comprising said compound; process for preparing said compound; intermediate compounds; and use of said compound to control phytopathogenic fungi and reduce mycotoxins. | |
MX2014000366A (en) | Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1 ,2,4]triazol-1-yl-ethanol compounds. | |
NZ600119A (en) | Process and intermediates for the preparation of 5-biphenyl-4-yl-2-methylpentanoic acid derivatives | |
TW200716107A (en) | Polymorphs of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazole-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester | |
PE20170662A1 (en) | AMINOPYRIDYLOXIPYRAZOLE COMPOUNDS | |
TW201129555A (en) | Process for the manufacture of dabigatrane etexilate | |
MX2018007513A (en) | Method for producing 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)ph enyl]-1-(1,2,4-triazol-1-yl)propan-2-ol. | |
MY145141A (en) | Reactive distillation for the dehydration of mixed alcohols | |
PE20141408A1 (en) | AMINOQUINAZOLINES AS KINASE INHIBITORS | |
MY173846A (en) | Ester pro-drugs of [3-(1-(1h-imidazol-4-yl)ethyl)-2-methylphenyl] methanol | |
WO2014188453A3 (en) | Novel process for the preparation of 2-[4-(2-{4-[1-(2-ethoxyethyl)-1h-benzimidazol-2-yl]-1-piperidinyl}ethyl) phenyl]-2-methylpropanoic acid | |
MX2023000044A (en) | Novel processes and intermediates for the preparation of soluble guanylate cyclase stimulators. | |
WO2007013096A8 (en) | Improved process for the preparation of 2r, 3s-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl) butan-2-ol (voriconazole) | |
CN105254567A (en) | Method for preparing dexmedetomidine hydrochloride key intermediate | |
EP4249488A3 (en) | Novel processes for preparation of soluble guanylate cyclase stimulators | |
MX346347B (en) | Method for producing 2-(triazinylcarbonyl) sulfonanilides. | |
EA201990236A1 (en) | NEW METHODS FOR PRODUCING STIMULANTS OF SOLUBLE GUANILATICYCLASE | |
GEP20125681B (en) | A one-pot process for preparing 3-(2,2,2-trimethylhydrazinium) propionate dihydrate | |
BR112022007102A2 (en) | METHODS FOR THE PREPARATION OF 5-BROMO-2-(3-CHLORO-PYRIDIN-2-IL)-2H-PYRAZOL-3-CARBOXYLIC ACID | |
WO2009116072A3 (en) | Process for preparation of pyridinylmethylsulphinyl benzimidazole compounds and pyridine intermediates | |
MX2009012706A (en) | Process for preparing triazolones. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |